Sleep disturbance related symptoms are common in patients with long-term oxygen therapy (LTOT). Essentially, there were only few previous reports about the sleep architecture in patients with respiratory disease, such as chronic obstructive pulmonary disease (COPD). This study aims to clarify the objective sleep state and the elements that affect sleep architecture in Chronic Respiratory Failure (CRF) patients with focus on clinical cases of chronic hypercapnia. 13 subjects with chronic respiratory failure were enrolled in the study. All the subjects were pre-evaluated by pulmonary function test and Arterial blood gas analysis (ABG) including exercise testing. Polysomnography (PSG) test was performed in each subject with supplemental oxygen. The estimated base line PaCO2 value that reflects overall PaCO2 including sleep period was calculated using equation of PaCO2[2.4×(HCOˉ3)-22]from obtained ABG value just before PSG test. 6 subjects were classified as hypercapnic group (base line PaCO2 ≥ 45 mmHg) and 7 subjects were non-hypercapnic group (base line PaCO2 < 45 mmHg). Latency persistent sleep of PSG data was significant higher in patients with hypercapnic than non-hypercapnic (p < 0.01). Periodic Limb Movement was seen in 23.6% of the subjects, however there was no contribution for arousals. Other PSG data include mean SpO2 were no significant difference. This study suggests that patients with estimated hypercapnia had more disturbed sleep architecture especially significant loss of sleep latency than non-hypercapnic patient with chronic respiratory failure under LTOT. Nocturnal PaCO2 level or ventilatory function may contribute to sleep disturbance in patients with estimated hypercapnia during LTOT.
 Croxton, T.L. and Bailey, W.C. (2006) Long-term oxygen treatment in chronic obstructive pulmonary disease: Recommendations for future research: An NHLBI workshop report. American Journal of Respiratory and Critical Care Medicine, 174, 373-378. doi:10.1164/rccm.200507-1161WS
 Rabe, K.F. and Hurd, S. (2007) Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American Journal of Respiratory and Critical Care Medicine, 176, 532-555. doi:10.1164/rccm.200703-456SO
 Karachaliou, F. and Kostikas, K. (2007) Prevalence of sleep-related symptoms in a primary care population— Their relation to asthma and COPD. Primary Care Respiratory Journal, 16, 222-228. doi:10.3132/pcrj.2007.00045
 Fleetham, J. and West, P. (1982) Sleep, arousals, and oxygen desaturation in chronic obstructive pulmonary disease. The effect of oxygen therapy. American Review of Respiratory Disease, 126, 429-433.
 Fleetham, J. and West, P. (1982) Sleep, arousals, and oxygen desaturation in chronic obstructive pulmonary disease. The effect of oxygen therapy. American Review of Resp ratory Disease, 126, 429-433.
 Lugaresi, E. and Coccagna, G. (1972) Some periodic phenomena arising during drowsiness and sleep in man. Electroencephalography and Clinical Neurophysiology, 32, 701-705. doi:10.1016/0013-4694(72)90106-X
 Wolff, H. and Lennox, W. (1930) The cerebral corculation. The effect on pial vessels of variations in the O2 and CO2 content of the blood. Arch Neurol Psychiatry, 23, 1097-1120. doi:10.1001/archneurpsyc.1930.02220120002001
 Harper, A.M. and Glass, H.I. (1965) Effect of alterations in the arterial carbon dioxide tension on the blood flow through the cerebral cortex at normal and low arterial blood pressures. Journal of Neurology, Neurosurgery & Psychiatry, 28, 449-452. doi:10.1136/jnnp.28.5.449
 Severinghaus, J.W. and Lassen, N. (1967) Step hypocapnia to separate arterial from tissue PCO2 in the regulation of cerebral blood flow. Circulation Research, 20, 272-278. doi:10.1161/01.RES.20.2.272